Announced
Completed
Financials
Tags
health care
medical devices
Single Bidder
Private
Completed
Cross Border
Friendly
Acquisition
United States
Majority
Health Care Services
Synopsis
Alliance Pharma, a distributor of consumer healthcare brands and prescription medicines, completed the acquisition of ScarAway, a silicone-based scar treatment brand, from Perrigo, a manufacturer of over-the-counter self-care products and supplier of infant formulas for the store brand market, for £14.8m. "I'm delighted to have completed such a strategically important and earnings enhancing acquisition for Alliance which creates our first fully global brand in Kelo-cote and significantly enhances our presence in the largest consumer healthcare market in the world," Peter Butterfield, Alliance Chief Executive Officer.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.